Particle Size Distribution Oos in MDI assembly: device qualification and crimp validation controls


Published on 30/12/2025

Addressing Out of Specification Issues in Particle Size Distribution During MDI Assembly

Particle size distribution (PSD) is critical in the assembly of Metered Dose Inhalers (MDIs). Out of Specification (OOS) results in PSD can have profound implications for product efficacy and patient safety. This article explores how to investigate OOS results effectively, focusing on symptoms, likely causes, containment actions, and CAPA strategies, while ensuring compliance with regulatory expectations.

After reading this article, pharmaceutical professionals will be equipped with a structured approach to investigating OOS findings related to PSD in MDIs, enabling accurate identification of the root cause and effective implementation of corrective and preventive actions.

Symptoms/Signals on the Floor or in the Lab

Detection of OOS results for PSD typically surfaces as deviations reported during quality control testing of MDI products. Symptoms may include:

  • Unexpected results in batch release testing for particle size, where measured values fall outside pre-defined acceptance criteria.
  • Inconsistencies in historical PSD trends, with spikes in particle size variance that were not previously observed.
  • Increased customer complaints regarding product performance, including
reduced efficacy or inconsistent delivery of the active pharmaceutical ingredient (API).
  • Observations of spray pattern and plume geometry defects during device functionality testing.
  • Each of these symptoms requires immediate attention to identify the underlying cause. Regular monitoring and trending of PSD data are crucial to detect deviations early, potentially avoiding larger quality issues.

    Explore the full topic: Aerosol Formulations

    Likely Causes

    To methodically approach the investigation, potential root causes can be categorized into six areas: Materials, Method, Machine, Man, Measurement, and Environment.

    Category Potential Causes
    Materials Variability in raw materials (e.g., API, excipients), improper storage conditions, or expired materials.
    Method Inadequate sample preparation, improper testing procedures, or use of non-validated test methods.
    Machine Equipment malfunction, such as calibration drift or wear, and changes in operational parameters without re-validation.
    Man Insufficient operator training, fatigue, or deviations from standard operating procedures (SOPs).
    Measurement Instrumentation errors, lack of method validation or control, or improperly maintained measurement devices.
    Environment Environmental conditions affecting product performance, such as temperature and humidity fluctuations in the manufacturing area.

    Understanding these potential causes enables a targeted investigation and helps in narrowing down the search for the root cause.

    Immediate Containment Actions (first 60 minutes)

    When OOS results are identified, immediate containment actions are critical to prevent further impact on the production batch and subsequent releases. Key steps include:

    1. Stop the production process to prevent additional impact.
    2. Quarantine all affected products, materials, and equipment.
    3. Review sampling and testing procedures to ensure compliance with established protocols.
    4. Notify appropriate stakeholders including Quality Control (QC), Quality Assurance (QA), and Production Management.
    5. Document all actions taken in real-time to ensure traceability and compliance during investigations.

    Prompt action helps to limit the scope of investigation and provides a foundation for assessing the impact of the OOS results.

    Investigation Workflow (data to collect + how to interpret)

    The investigation workflow is critical for systematically addressing the issue. Key data points to collect include:

    • Batch records detailing the production process, including critical parameters.
    • Quality Control test results, including historical data on PSD and other relevant metrics.
    • Raw materials specifications and Certificate of Analysis (CoA) for each lot used.
    • Equipment calibration and maintenance records over the running period of the batch.
    • Environmental condition logs during manufacturing and testing.
    • Operator training records to verify adherence to SOPs.

    To interpret the collected data effectively:

    • Analyze batch records to identify anomalies in processing conditions.
    • Trend PSD results over time to identify patterns or shifts towards OOS over multiple batches.
    • Correlate environmental conditions with OOS occurrences to determine if these factors played a role.

    Data interpretation is necessary to identify potential leads for the investigation.

    Root Cause Tools

    Utilizing structured root cause analysis tools can enrich the investigation process. Common tools include:

    • 5-Why Analysis: This tool involves asking ‘why’ iteratively until the root cause is identified. Effective for straightforward problems where a single root cause is expected.
    • Fishbone Diagram: Also known as Ishikawa or cause-and-effect analysis, this tool organizes potential causes by category, enabling a visual representation of factors contributing to the OOS result.
    • Fault Tree Analysis (FTA): A more complex analysis type that provides a structured and thorough approach, useful for analyzing systems with intertwined components.

    Selecting the right tool depends on the complexity of the identified issues. For straightforward issues, 5-Why can be effective, whereas Fishbone and FTA are preferable for multifactorial problems.

    CAPA Strategy

    Establishing and implementing a robust CAPA strategy is essential for addressing the detected root causes. This involves three key components:

    • Correction: Immediate actions taken to rectify the specific OOS issue identified. For example, reviewing the PSD test results to validate accuracy and identify initial error sources.
    • Corrective Action: Long-term actions aimed at eliminating the root cause, which might involve revising SOPs, enhancing training programs, upgrading equipment, and improving material testing protocols.
    • Preventive Action: Strategies to ensure similar issues do not recur in the future. This might include routine monitoring of PSD and environmental conditions as well as implementing additional safeguards in the production process.

    Complete documentation of the CAPA strategy must be maintained to demonstrate compliance during inspections and facilitate continuous improvement.

    Control Strategy & Monitoring

    A robust control strategy is critical in ensuring that OOS events are minimized and managed effectively. Components include:

    Related Reads

    • Statistical Process Control (SPC): Implementing SPC for PSD measurements allows for monitoring process stability and detecting trends over time.
    • Sampling Plan Enhancements: Adjusting the sampling plan to include more frequent or targeted sampling can help catch potential OOS scenarios before product release.
    • Alarm Systems: Using alarms to alert operators if PSD approaches action limits during production can ensure timely interventions.
    • Verification Processes: Regular audits and checks of processes, equipment, and outputs ensure adherence to established control limits.

    The effectiveness of the control strategy should be periodically reviewed and optimized based on ongoing monitoring data.

    Validation / Re-qualification / Change Control Impact

    Any changes resulting from root cause investigations and CAPA actions may require re-validation, re-qualification, or change control submissions. Key considerations include:

    • Assess whether changes in materials, processes, or equipment necessitate a new validation exercise.
    • Determine if a change control procedure is required based on the significant nature of the changes made.
    • Ensure all revised processes undergo re-testing to validate that they meet PSD specifications.

    Failure to address these elements adequately may result in non-compliance during inspections by regulatory agencies like the FDA or EMA.

    Inspection Readiness: What Evidence to Show

    To ensure inspection readiness following a deviation investigation, it is crucial to compile and present comprehensive documentation. Evidence should include:

    • Records of monitoring and testing data on PSD before and after the OOS incident.
    • Documentation of all corrective actions taken, including effectively implemented changes and follow-up verifications.
    • Batch production records and logs demonstrating adherence to standard operating procedures.
    • Deviation reports as per GMP requirements, outlining the investigations and CAPA implemented in response to the OOS results.
    • Training records showing operator competency and compliance with production and testing protocols.

    Maintaining clear records not only supports inspection readiness but also fosters a culture of continuous improvement and compliance throughout the organization.

    FAQs

    What should the acceptance criteria for PSD be?

    Acceptance criteria for PSD should be determined based on product specifications, synergistic analysis, and regulatory guidance, typically encompassing the targeted range for effective delivery and safety.

    How often should PSD be tested in MDI products?

    PSD testing frequency should correlate with historical data trends, regulatory guidelines, and the production volume, ensuring thorough monitoring without excessive testing burden.

    Can environmental factors affect PSD in MDIs?

    Yes, environmental factors like humidity and temperature can influence the manufacturing and stability of particle size, necessitating strict control measures.

    What regulatory guidelines cover PSD for MDIs?

    Regulatory guidelines from agencies such as the FDA, EMA, and ICH provide comprehensive frameworks for quality measures regarding PSD in MDIs, often referring to the importance of specifications defined in marketing applications.

    How do I train staff on handling PSD OOS investigations?

    Training should encompass a robust curriculum around OOS investigations, including identification, documentation, and CAPA processes, supplemented by practical case studies and simulations.

    What documentation is crucial for OOS investigations?

    Critical documentation includes batch records, deviation reports, CAPA documentation, training records, and equipment calibration logs.

    What is the role of SPC in managing PSD?

    SPC aids in monitoring and controlling the production process, helping to identify trends in PSD data, allowing for timely interventions before OOS results occur.

    How can repeat OOS incidents be prevented?

    Implementing effective CAPA actions, enhancing training, rigorous monitoring, and regular reviews of the quality control strategy can mitigate the risk of repeat incidents.

    What should I do if our MDI fails PSD testing?

    Immediate containment actions should be taken including quarantine of the product, followed by a thorough investigation and CAPA implementation as described in this article.

    Where can I find more information on regulatory expectations for PSD?

    Regulatory expectations can be found in documents published by the FDA, EMA, and other authoritative bodies covering product quality standards.

    What advance planning is needed for an OOS incident?

    Establishing robust monitoring, trending capability, and an effective response and training protocol will facilitate prompt response and minimize impact in case of OOS findings.

    Pharma Tip:  Scaling Up Aerosol Production Without Compromising Quality